| Anti-DKK1 mAb (BHQ880) as a potential therapeutic agent for multiple myeloma M Fulciniti, P Tassone, T Hideshima, S Vallet, P Nanjappa, SA Ettenberg, ... Blood, The Journal of the American Society of Hematology 114 (2), 371-379, 2009 | 469 | 2009 |
| Elevated IL-17 produced by Th17 cells promotes myeloma cell growth and inhibits immune function in multiple myeloma RH Prabhala, D Pelluru, M Fulciniti, HK Prabhala, P Nanjappa, W Song, ... Blood, The Journal of the American Society of Hematology 115 (26), 5385-5392, 2010 | 394 | 2010 |
| The identification of zebrafish mutants showing alterations in senescence-associated biomarkers S Kishi, PE Bayliss, J Uchiyama, E Koshimizu, J Qi, P Nanjappa, ... PLoS genetics 4 (8), e1000152, 2008 | 173 | 2008 |
| A high-affinity fully human anti–IL-6 mAb, 1339, for the treatment of multiple myeloma M Fulciniti, T Hideshima, C Vermot-Desroches, S Pozzi, P Nanjappa, ... Clinical Cancer Research 15 (23), 7144-7152, 2009 | 142 | 2009 |
| HDAC inhibition by LBH589 affects the phenotype and function of human myeloid dendritic cells W Song, YT Tai, Z Tian, T Hideshima, D Chauhan, P Nanjappa, MA Exley, ... Leukemia 25 (1), 161-168, 2011 | 114 | 2011 |
| Anticancer activity of a broccoli derivative, sulforaphane, in barrett adenocarcinoma: potential use in chemoprevention and as adjuvant in chemotherapy A Qazi, J Pal, M Maitah, M Fulciniti, D Pelluru, P Nanjappa, S Lee, ... Translational oncology 3 (6), 389-399, 2010 | 108 | 2010 |
| Functional aging and gradual senescence in zebrafish S Kishi Annals of the New York Academy of Sciences 1019 (1), 521-526, 2004 | 105 | 2004 |
| Screen for genes differentially expressed during regeneration of the zebrafish caudal fin BK Padhi, L Joly, P Tellis, A Smith, P Nanjappa, M Chevrette, M Ekker, ... Developmental dynamics: an official publication of the American Association …, 2004 | 102 | 2004 |
| Targeting IL-17A in multiple myeloma: a potential novel therapeutic approach in myeloma RH Prabhala, M Fulciniti, D Pelluru, N Rashid, A Nigroiu, P Nanjappa, ... Leukemia 30 (2), 379-389, 2016 | 67 | 2016 |
| Significant biological role of sp1 transactivation in multiple myeloma M Fulciniti, S Amin, P Nanjappa, S Rodig, R Prabhala, C Li, S Minvielle, ... Clinical Cancer Research 17 (20), 6500-6509, 2011 | 58 | 2011 |
| Targeting homologous recombination and telomerase in Barrett’s adenocarcinoma: impact on telomere maintenance, genomic instability and tumor growth R Lu, J Pal, L Buon, P Nanjappa, J Shi, M Fulciniti, YT Tai, L Guo, M Yu, ... Oncogene 33 (12), 1495-1505, 2014 | 49 | 2014 |
| Nucleotide excision repair is a potential therapeutic target in multiple myeloma R Szalat, MK Samur, M Fulciniti, M Lopez, P Nanjappa, A Cleynen, K Wen, ... Leukemia 32 (1), 111-119, 2018 | 44 | 2018 |
| Role of apurinic/apyrimidinic nucleases in the regulation of homologous recombination in myeloma: mechanisms and translational significance S Kumar, S Talluri, J Pal, X Yuan, R Lu, P Nanjappa, MK Samur, ... Blood cancer journal 8 (10), 92, 2018 | 39 | 2018 |
| CTX-8573, an innate-cell engager targeting BCMA, is a highly potent multispecific antibody for the treatment of multiple myeloma J Watkins-Yoon, W Guzman, A Oliphant, S Haserlat, A Leung, C Chottin, ... Blood 134, 3182, 2019 | 33 | 2019 |
| Targeting PI3K and RAD51 in Barrett’s adenocarcinoma: impact on DNA damage checkpoints, expression profile and tumor growth J Pal, M Fulciniti, P Nanjappa, L Buon, YT Tai, P Tassone, NC Munshi, ... Cancer genomics & proteomics 9 (2), 55-66, 2012 | 14 | 2012 |
| Impact of RAD51C-mediated homologous recombination on genomic integrity in Barrett’s adenocarcinoma cells J Pal, P Nanjappa, S Kumar, J Shi, L Buon, NC Munshi, MA Shammas Journal of gastroenterology and hepatology research 6 (1), 2286, 2017 | 12 | 2017 |
| Amplification and overexpression of E2 ubiquitin conjugase UBE2T promotes homologous recombination in multiple myeloma DA Alagpulinsa, S Kumar, S Talluri, P Nanjappa, L Buon, C Chakraborty, ... Blood Advances 3 (23), 3968-3972, 2019 | 11 | 2019 |
| Lack of Response to Vaccination in MGUS and Stable Myeloma. RH Prabhala, YA Efebera, S Lee, AJ Han, D Pelluru, P Nanjappa, S Amin, ... Blood 114 (22), 1852, 2009 | 8 | 2009 |
| Elevated APE1 mediates dysregulation of homologous recombination in myeloma: mechanisms and translational significance S Kumar, M Gkotzamanidou, J Pal, R Lu, P Nanjappa, J Shi, M Shammas, ... Blood 124 (21), 2074, 2014 | 3 | 2014 |
| Human Monoclonal Antibody Targeting IL-17A (AIN457) Down-Regulates MM Cell-Growth and Survival and Inhibits Osteoclast Development In Vitro and In Vivo: A Potential Novel … RH Prabhala, M Fulciniti, D Pelluru, P Nanjappa, C Pai, S Lee, ... Blood 116 (21), 456, 2010 | 3 | 2010 |
